Zinc and prostate cancer
This article was originally published in The Tan Sheet
Executive Summary
A study finds "no statistically significant association" between zinc supplementation and prostate cancer risk, according to a letter in the Journal of the National Cancer Institute by the study authors. Ellen Chang, Karolinska Institute, Stockholm, et al., conducted a population-based case-control study among 1,499 prostate cancer patients and 1,130 control subjects, finding no increase in prostate cancer risk arising from supplemental zinc use categorized by frequency, duration or cumulative exposure. The results contradict a 2003 JNCI study that reported a greater risk of prostate cancer among users of supplemental zinc (1"The Tan Sheet" July 14, 2003, In Brief)...
A study finds "no statistically significant association" between zinc supplementation and prostate cancer risk, according to a letter in the Journal of the National Cancer Institute by the study authors. Ellen Chang, Karolinska Institute, Stockholm, et al., conducted a population-based case-control study among 1,499 prostate cancer patients and 1,130 control subjects, finding no increase in prostate cancer risk arising from supplemental zinc use categorized by frequency, duration or cumulative exposure. The results contradict a 2003 JNCI study that reported a greater risk of prostate cancer among users of supplemental zinc (1 'The Tan Sheet' July 14, 2003, In Brief).... |